This inventor holds 4 USPTO granted patents. Top assignees: Hycor Biomedical, LLC, Hematronix, Inc., Streck Laboratories, Inc.. Active years: 1999-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 26 
1 out of 6 
1 out of 41 
Years Active: 1999-2001
Title: Wayne R Hengstenberg: Innovator in Erythrocyte Sedimentation Rate Control
Introduction
Wayne R Hengstenberg is a notable inventor based in Clark, NJ (US). He has made significant contributions to the field of medical diagnostics, particularly in the development of erythrocyte sedimentation rate controls. With a total of four patents to his name, Hengstenberg's work has had a meaningful impact on the accuracy of blood analysis.
Latest Patents
Hengstenberg's latest patents focus on a three-phase suspension designed for use as an erythrocyte sedimentation rate control. This innovative control comprises three essential components: a synthetic plasma base, a high molecular weight polymer, and mammalian red blood cells. The design allows users to effectively monitor the accuracy and precision of analytical methods for determining the sedimentation rate of human erythrocytes in whole blood specimens.
Career Highlights
Throughout his career, Wayne R Hengstenberg has worked with various organizations, including Hycor Biomedical, LLC. His experience in the biomedical field has equipped him with the knowledge and skills necessary to develop advanced diagnostic tools.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Wayne R Hengstenberg's contributions to medical diagnostics through his innovative patents demonstrate his commitment to improving healthcare. His work continues to influence the field and enhance the accuracy of blood analysis methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile